1. Home
  2. CYTH vs ATER Comparison

CYTH vs ATER Comparison

Compare CYTH & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTH
  • ATER
  • Stock Information
  • Founded
  • CYTH 1990
  • ATER 2014
  • Country
  • CYTH United States
  • ATER United States
  • Employees
  • CYTH N/A
  • ATER N/A
  • Industry
  • CYTH Biotechnology: Pharmaceutical Preparations
  • ATER Home Furnishings
  • Sector
  • CYTH Health Care
  • ATER Consumer Discretionary
  • Exchange
  • CYTH Nasdaq
  • ATER Nasdaq
  • Market Cap
  • CYTH 26.2M
  • ATER 22.8M
  • IPO Year
  • CYTH N/A
  • ATER N/A
  • Fundamental
  • Price
  • CYTH $0.80
  • ATER $2.18
  • Analyst Decision
  • CYTH Buy
  • ATER Strong Buy
  • Analyst Count
  • CYTH 3
  • ATER 1
  • Target Price
  • CYTH $0.95
  • ATER N/A
  • AVG Volume (30 Days)
  • CYTH 52.2K
  • ATER 48.1K
  • Earning Date
  • CYTH 03-17-2025
  • ATER 03-11-2025
  • Dividend Yield
  • CYTH N/A
  • ATER N/A
  • EPS Growth
  • CYTH N/A
  • ATER N/A
  • EPS
  • CYTH N/A
  • ATER N/A
  • Revenue
  • CYTH $870,725.00
  • ATER $107,193,000.00
  • Revenue This Year
  • CYTH N/A
  • ATER N/A
  • Revenue Next Year
  • CYTH $24.49
  • ATER $5.47
  • P/E Ratio
  • CYTH N/A
  • ATER N/A
  • Revenue Growth
  • CYTH N/A
  • ATER N/A
  • 52 Week Low
  • CYTH $0.55
  • ATER $0.23
  • 52 Week High
  • CYTH $2.12
  • ATER $3.95
  • Technical
  • Relative Strength Index (RSI)
  • CYTH 70.05
  • ATER 40.46
  • Support Level
  • CYTH $0.76
  • ATER $2.18
  • Resistance Level
  • CYTH $0.86
  • ATER $2.35
  • Average True Range (ATR)
  • CYTH 0.07
  • ATER 0.13
  • MACD
  • CYTH 0.03
  • ATER -0.01
  • Stochastic Oscillator
  • CYTH 92.58
  • ATER 8.19

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

About ATER Aterian Inc.

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operated brands including Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.

Share on Social Networks: